Bonde, T.M. et al. 2023. Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists. Acta Oncologica. 62, 12 (Dec. 2023), 1815–1821. DOI:https://doi.org/10.1080/0284186X.2023.2269600.